Clinical trial

A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma

NCT01199289

Study summary

ClinicalTrials.gov

A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention AMG 827 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-10-04

PhasePHASE2

Conditions

Asthmaverified · MONDO: asthma

Interventions

AMG 827DRUG

PlaceboDRUG

Sponsors & collaborators

Amgenlead sponsor

Mapped research locations

Los AngelesCalifornia, United States1 DallasTexas, United States1 BaltimoreMaryland, United States1 St LouisMissouri, United States1 TorontoOntario, Canada1 SeoulSouth Korea1 PittsburghPennsylvania, United States1 CincinnatiOhio, United States1 San DiegoCalifornia, United States1 MoscowRussia1 Saint PetersburgRussia1 BrusselsBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01199289 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.